Immunology

The medicine of the future against infection and inflammation?

Researchers at Lund University in Sweden, have in collaboration with colleagues in Copenhagen and Singapore, mapped how the body's own peptides act to reduce infection and inflammation by deactivating the toxic substances ...

Immunology

Restricting unwanted immune reactions

The immune system often initiates its response to pathogens by activating immune cells, so-called phagocytes, which migrate to sites of inflammation. There, the phagocytes release certain proteins, including the S100A8/S100A9 ...

Cardiology

How the flu affects your heart

Amid the most intense flu season in more than a decade, a new study published in the The New England Journal of Medicine confirms that the flu virus significantly raises your risk of having a heart attack within a week of ...

Diseases, Conditions, Syndromes

Patient's psoriasis improves with initiation of hepatitis C therapy

Researchers report the first case of a patient whose psoriasis improved when therapy for his hepatitis C virus (HCV) infection was initiated. Findings from a brief case report are published in Annals of Internal Medicine.

Immunology

How cytoplasmic DNA triggers inflammation in human cells

A team led by LMU's Veit Hornung has elucidated the mechanism by which human cells induce inflammation upon detection of cytoplasmic DNA. Notably, the signal network involved differs from that used in the same context in ...

Immunology

Fighting allergies by silencing immune cells

University of Queensland researchers are one step closer to developing new medicines for treating inflammatory diseases, including allergies such as rhinitis, itchy hives, asthma, eczema and dermatitis.

Immunology

Titanium dioxide nanoparticles can exacerbate colitis

Titanium dioxide, one of the most-produced nanoparticles worldwide, is being used increasingly in foodstuffs. When intestinal cells absorb titanium dioxide particles, this leads to increased inflammation and damage to the ...

page 1 from 8